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Abstract
To reduce recidivism, many correctional programs and interventions have been introduced to
offenders. Though, the rate of recidivism remains exceedingly high. To improve program
outcomes, it is important to match the dosage of a program to risk levels. However, there is not a
standardized definition and measurement of program dosage. This thesis extends the study on
identifying the definition and measurement of dosage and the effectiveness of the programs by
conducting a systematic review of prior research. The results indicate that as a treatment dosage,
treatment duration was more frequently used compared to treatment intensity to reduce
recidivism rate of the incarcerated participants. However, due to limited sources more data must
be searched and identified for further study
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Chapter One: Introduction
According to the U.S. Department of Justice (DOJ), the U.S. prison population reached
over 1 million by the end of 2019 (Carson, 2020). The high incarceration rate may lead to
overcrowding of correctional facilities, which is one of the biggest problems in our criminal justice
system. One way to reduce the incarceration rate is to help released individuals avoid recommitting
crimes. According to the DOJ, the incarceration rate increased every year from 2005 to 2014, with
an 83% rearrest rate after nine years of release (Alper, Durose et al, 2018).
One of the best ways to reduce the recidivism rate is to provide effective interventions.
There are many different types of interventions provided to offenders, including cognitivebehavioral therapy (Allen et al.,2001; Lipsey et al., 2007; Lipsey et al., 2001; Pearson et al., 2002),
educational treatment (Davis et al., 2013; Davis et al., 2014; Hall, 2015; Jancic, 1998), and
substance abuse treatment (Ashley et al., 2003; Mccollister et al., 2003). Such programs do not
only curtail the recidivism rate but also reduce individuals' criminal behavior.
In his 1974 study, "What works? – questions and answers about prison reform,” Robert
Martinson purports that rehabilitation programs are not effective in decreasing recidivism. To
refute these claims, many studies have been conducted studying the efficiency of correction
programs in an effort to reduce the likelihood of inmates reentering prison (Allen et al., 2001;
Landenberger & Lipsey, 2005; Pearson et al., 2002; Peter, Haas, & Hunt, 2001; Sperber &
Lowenkamp, 2017; Wikoff et al., 2012). While Martinson suggests that rehabilitation treatment is
largely ineffective, subsequent studies have found that rehabilitation programs have the ability to
reduce the recidivism rate.
Treatment dosage is an essential factor in how correctional treatment programs impact
recidivism (Andrews & Bonta, 2010). Treatment dosage is often described as how long or how
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frequently participants participate in the assigned correctional program; however, it is measured
differently in each study. According to Duwe (2017), treatment dosage does affect the offender's
future criminal behavior, especially for high-risk offenders. This study will focus on how treatment
dosage was construed in different correctional interventions, the outcomes of programs based on
different treatment dosages, and how treatment dosage was applied to individuals of different risk
levels (Sperber & Lowenkamp, 2017). Specifically, the goal is to identify how dosage is defined
and measured in correctional intervention research to reduce recidivism after participants' release.
The study aims to determine effective treatment dosages for each risk level group.
Purpose and goal of the study
According to Collins et al. (2004), a standardized measurement of treatment dosage does not
currently exist, because treatment dosage depends on several factors present in each study,
including individuals’ needs, risk levels, and types of interventions. Since each study has its own
unique strategies and research goals, different correctional interventions require different treatment
dosages (Landenberger & Lipsey, 2005; Davis et al., 2013; Evans et al., 2011). In particular,
relatively little is known about whether treatment dosage should be measured by treatment duration
(hours, days, and years), program completion, or other methods.
Having detailed program dosage information is essential to operationalizing treatment dosage
in correctional treatment programs for offenders. This study identifies different types of treatment
dosage and the definitions used in each study. It also aims to discuss whether various approaches
to treatment dosage reduce the recidivism rate. Generally speaking, this study seeks to understand
what treatment dosage is and how it affects recidivism. The research questions include:
1.

How is program dosage defined in correctional intervention programs?

2.

How is treatment dosage measured in correctional intervention programs?
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3.

Based on different risk-level, what is the most effective treatment dosage to reduce
the risk of recidivism?

Theoretical Framework for the Current Research Project
The Risk-Need-Responsivity (RNR) theory guides offender assessment and effectively
identifies individuals' needs to reduce recidivism (Andrews et al., 2011). Identifying the offenders
by their characteristics and risk, need, and responsivity of individuals provides a foundation of the
correctional interventions and drives the selection and implementation of right correctional
services (Andrews et al, 2011; Andrews et al., 1990; Latessa & Lowenkamp, 2006; Taxman &
Marlowe, 2006; Ward et al, 2007).
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Chapter Two: Literature Review
Nearly 2 million people are incarcerated in the United States; 95 percent of them will
reenter their communities (Alper & Durose, 2018). However, studies from the Department of
Justice (DOJ) show that across 34 states, nearly 1.1 million arrests occurred in the 5-year followup period among the approximately 408,300 prisoners who were released in 2012. Approximately
62% of released prisoners were rearrested and back in prison within three years, and 71% returned
to prison within five years (Durose & Antenangeli, 2021).
By scrutinizing the fundamental factors in correctional interventions, we can take action
to reduce the recidivism rate. Moreover, providing effective interventions can solve far-reaching
correctional concerns, such as the excessive populations of correction facilities and high
corrections expenditures at the federal, state, and local levels. One way to reduce recidivism is to
offer appropriate correctional programs for incarcerated inmates: academic programs, cognitive
behavioral therapy, and substance abuse treatment programs (Duwe, 2017). These correctional
treatment programs can help offenders avoid future criminal behavior and successfully assimilate
back into society without recommitting crimes.
What is recidivism?
Recidivism is generally defined as when a released offender returns to criminal behavior
(Cotter, 2020). There are multiple measures of recidivism, including rearrest, reconviction, and/or
reincarceration (Alper & Durose, 2018; Cotter, 2020; Hunt et al., 2019; Kyckelhahn & Cooper,
2017). Rearrest is when an offender is arrested for a new crime after being released. This also
includes arrests for violations of supervised releases, probation, or state parole (Hunt et al., 2019;
Kyckelhahn & Cooper, 2017). Reconviction is when a new arrest after release results in a
subsequent court conviction (Hunt et al., 2019; Kyckelhahn & Cooper, 2017). Violations of
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supervised releases, probation, or state parole are not considered reconviction due to the absence
of formal prosecution. Finally, reincarceration is when an individual is resentenced to either jail or
prison (Hunt et al., 2019; Kyckelhahn & Cooper, 2017).
Measuring recidivism can be difficult and each measure has limitations. Not all crimes are
discovered by police, and not all crimes result in arrest. Furthermore, some people are arrested but
then subsequently acquitted. Consequently, it can be challenging to determine the actual rate of
recidivism (Calley, 2012; Peters et al., 2001; Stewart et al., 2014; Turner et al., 2000). Rearrest is
often used to measure recidivism, because the data is easier to collect than data related to
reconviction and reincarceration (Kyckelhahn & Cooper, 2017).
Recidivism trends
As previously stated, recidivism is a significant problem in the United States. The Bureau
of Justice Statistics (BJS) 2018 research update shows that prisoners in their first year after release
showed the highest arrest rate: about four in nine (44%). By the ninth year, the rate is about one in
four (24%) (Alper et al, 2018). For 401,288 prisoners released in 2005, around 1,994,000 arrests
were recorded during the first nine years post-release. Moreover, about 82% of prisoners were
arrested within the first three years (Alper et al, 2018). This data helps us understand the trend of
recidivism. The rate of prisoners being rearrested increased during each of the nine years, from
2005 to 2014. 68 percent were arrested within three years, and 83 percent were arrested within
nine years. Therefore, to be succinct, the longer the release period, the higher the rate of rearrest
among individuals released from prison.
Risk-Need-Responsivity model:
Before researchers carry out correctional research, they should identify individuals'
characteristics, needs, and correctional treatments to determine whether such factors could bring
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out the answers to their research questions. Particularly for examining the effectiveness of
interventions, understanding the risk levels and needs of participants could provide more accurate
outcomes. The Risk-Need-Responsivity (RNR) model is widely regarded as a useful tool for
offender assessment and treatment and offers guidance for how offenders’ criminological behavior
should be implicated in the selection and implementation of correctional interventions (Andrews
et al., 2011; Seewald et al., 2018; Taxman & Marlowe, 2006; Ward et al., 2016). The RNR model
consists of a number of principles that guide interventions including the risk principle, need
principle, and responsivity principle (Andrews et al., 2011; Duwe, 2018; Latessa & Lowenkamp,
2006; Seewald et al., 2018; Taxman & Marlowe, 2006; Ward et al., 2016).
These three principles offer important implications for correctional intervention: who
should be treated (risk), what should be treated (need), and how the treatment should be carried
out (responsivity) (Andrews et al., 2011; Duwe, 2018; Latessa & Lowenkamp, 2006). These
principles have been linked to the ability of treatment to reduce recidivism; programs that fail to
adhere to these principles have been found to be less effective (Andrews et al., 2011; Bourgon &
Armstrong, 2005).
The risk principle states that a correctional program should match the level of service to
the risk level of the offender. For instance, it suggests that high-risk offenders will benefit the most
from high-intensity treatment or treatment with longer duration, while lower-risk offenders should
receive minimal, shorter, or no intervention (Andrews et al., 2011; Ward et al., 2016). Sperber et
al. (2013) found evidence to support the risk principle's effectiveness on recidivism. They
conducted a study on the relationship between risk and dosage, concluding that higher-risk
offenders benefit from higher levels of treatment. Mailloux et al. (2003)’s study of a high-risk
group of sex offenders indicated that these offenders needed to participate in more programs than
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other groups to achieve the same results. This study supports the risk principle, showing that that
high-risk offenders have to receive more intensive or more long-term treatment relative to lowerrisk offenders. This work also suggests that low-risk groups only need a limited amount of
treatment (Mailloux et al.,2003).
The need principle focuses on the criminogenic factors positively correlated with a
criminal offense or behavior (Andrews et al., 2011; Latessa & Lowenkamp, 2006; Seewald et al.,
2018). The RNR model divides the need principle into two different categories: criminogenic and
non-criminogenic needs (Hollin, 1999). Criminogenic needs are a subset of an offender's risk level
including the Central Eight risk/need factors: antisocial cognition, antisocial personality traits,
substance abuse, antisocial associates, family/marital circumstances, history of antisocial attitudes,
school/work, and leisure/recreation (Andrews et al., 2011; Hollin, 1999; Latessa & Lowenkamp,
2006). Non-criminogenic needs include stability factors such as housing, finances, and mental
health. Although non-criminogenic needs are also essential, changes in these factors are not
necessary for the probability of recidivism (Bourgon & Armstrong, 2005; Hollin, 1999).
The responsivity principle refers to a program's ability to match the style and mode of
intervention to the participants for whom it was designed (Andrews et al., 2011; Ward & Brown,
2004). Andrews et al. (2011) describe two types of responsivity: general and specific. General
responsivity is the use of behavioral, cognitive behavioral, and social learning approaches to
influence behavior; on the other hand, specific responsivity involves modifying strategies
according to the strengths, motivation, readiness to change, personality, mental status, learning
ability, learning style, circumstances, and demographics of individual cases (Andrews et al., 2011).
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Measuring risk level
As mentioned above, the RNR theory has three core principles: risk, need, and
responsivity. As noted, the risk principle has implications for intervention dosage. Based on the
RNR theory, higher risk level offenders receive higher levels of interventions because more
intensive treatment provides better outcomes (Andrews et al., 1990).
The methods used to measure risk levels can vary. There are several ways to measure the
risk of recidivism, including the use of standardized assessments. Examples of risk assessments
include the Level of Service Inventory-Revised (LSI-R) (Bechtel, 2016; Makarios et al., 2014;
Sperber et al., 2013), the Automated Criminal Risk Score (ACRS) (Duncan et al., 2018), and the
Spousal Assault Risk Assessment (SARA) (Stewart et al., 2014). Different assessments and
jurisdictions label risk levels differently. For example, an individual’s risk level can be identified
as low, moderate, or high risk (Bechtel, 2016; Cohen et al., 2016; Winokur et al., 2002), but some
assessments may also include low-moderate and moderate-high risk categories (Cohen et al., 2016;
Makarios et al., 2014).
Understanding, defining, and measuring dosage
Although research indicates that program dosage should match risk level, clear
requirements for defining and measuring risk do not currently exist. Researchers and programs use
different measures depending on the program, the risk assessment instrument, and other program
practices. Identifying a consistent measure of treatment dosage will help researchers assess the
link between dosage and program outcomes. Therefore, it is essential to figure out the most
appropriate program dosage for offenders of different risk levels. Having a standardized definition
and rate of program dosage will help develop new interventions with a high rate of positive
outcomes.
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This study aims to examine how treatment dosage is measured and how dosage affects the
correctional interventions to reduce recidivism. The academic literature addressing program
dosage and the criminal justice system is broad and varied. According to the risk principles
mentioned above, it is not yet clear how to match treatment dosages to different offender risk
levels. Therefore, this study focuses on identifying the most effective ways of defining and
measuring treatment dosage.
Treatment duration
Several studies have conceptualized dosage as the duration and intensity of interventions
delivered with the risk-need-responsivity (RNR) model to determine the most effective dosage for
participants of different risk levels (Bourgon & Armstrong, 2005; Landenberger & Lipsey, 2005;
Lipsey et al., 2007; Makarios et al., 2014; Mailloux et al., 2003; Sperber & Lowenkamp, 2017).
Treatment dosage is defined as how long participants participated in the program, while treatment
intensity refers to how frequently they participated within a certain period.
In a study conducted by Keeling et al. (2006), the special needs program cognitivebehavioral treatment lasted for 12 months, with moderate-risk offenders taking part for eight
months and high-risk offenders taking part for ten months. During those months, they usually
attended four days per week, which means they received the same number of programs but with a
different duration. In this study, treatment dosage was mainly referred to as duration, and the
offenders were involved in treatment for 12 months. Participants who completed the program
showed significant changes in their attitude, with positive effects on sexual behavior, victim
empathy, and self-control (Keeling et al., 2006).
Moreover, Makarios, Sperber, and Latessa (2014) described the relationship between
treatment dosage and recidivism by the different risk levels of offenders according to the Level of
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Service Inventory-Revised by Andrews and Bonta (1995, cited in Makarios et al., 2014). The
number of hours that individuals participated was considered to be the dosage, with 50-hour
increments from 100 to 299 hours: 100-149, 150-199, 200-249, 240-299, and more than 300 hours.
The impact of the refined dosage based on different risk levels was clearly illustrated in this study.
Low- and moderate-risk offenders showed that receiving 100-149 hours of treatment led to the
lowest recidivism rate, while high-risk offenders needed 150-199 hours. High- and moderate-risk
offenders showed a decrease in recidivism as the dosage increased.

Comparing the effects of

different dosages revealed that participating for more than 300 hours decreased the rate of
recidivism by 38% to 74% compared with participating for 150-199 hours
Sperber and Lowenkamp (2017) have reported the importance of a cognitive-behavioral
program and the appropriate amount of treatment to be served. Treatment dosage was measured as
the hours: 0-99 hours, 100-199 hours, and more than 200 hours. This study showed that the
recidivism rate of medium-risk offenders decreased when they achieved 100-199 hours of
treatment, while high-risk offenders should take 200 hours or more to see the reduction in rate.
Treatment intensity
Mailloux et al. (2003) analyzed Mailloux and Serin's (2001) study that emphasized the
importance of applying different treatment intensities to different risk level groups of offenders.
Because high-intensity groups have more risk factors, they should receive a higher number of
treatments than moderate and low-intensity groups. Therefore, dosage was defined as the number
of sessions completed or the intensity of intervention that different groups received to test their
hypotheses. As the risk level increases, treatment hours or the number of treatment sessions
increase; for example, in Mailloux et al.'s (2003) study, low-risk offenders received treatment for
two months, while the high-risk group received treatment for six to eight months. After treatment,
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the low-intensity group had significantly lower conviction rates than both the moderate- and highintensity groups, even though the latter groups participated in more programs for a more extended
period of time.
Sperber and Lowenkamp's (2017) research considered the duration and intensity of
treatment. Treatment intensity was measured as the number of treatments per week: none, one per
week, two per week, and more than three per week. A higher number of sessions per week and
participation in treatment involving role-playing were significantly related to participants'
recidivism rates after prison release.
Bourgon and Armstrong (2005) conducted a study comparing treatments of differing
lengths (5 weeks, 10 weeks, or 15 weeks) with similar levels of intensity. Treatment took place
five days per week, in two sessions approximately 2 to 2.5 hours long per day (Bourgon &
Armstrong, 2005). In this study, the treatment significantly reduced the recidivism rate for the
treated group by 10%; the one-year recidivism rate for the treated group was 31%, compared to
41.3% for the untreated control group.
Landenberger and Lipsey (2005) conducted a study to determine the effect of cognitive
behavioral therapy (CBT) on offenders' recidivism based on the amount of treatment completed.
The amount of treatment was measured by the number of treatment sessions per week. This study
recommended that the number of sessions per week has a stronger impact on program effectiveness
and recidivism rates than the number of hours.
Although treatment dosage is crucial for effective programs, the term dosage is often
defined and measured inconsistently in the correctional intervention (Rowbotham et al., 2019) or
not applied at all. Therefore, despite several studies on treatment dosage, there is no agreed upon
most appropriate definition and measurement of this term. However, treatment duration and
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intensity were identified as the most frequently used treatment dosage in the correctional
intervention to reduce recidivism. As mentioned above, the different studies used different
definitions of dosage, and two defining aspects of dosage were considered: program duration and
intensity. While these two factors could not yet be considered a generalized standard definition of
dosage, they were able to provide insight into how dosage should be measured.
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Chapter Three: Methodology
Before analyzing data for this systematic review, a search strategy was identified to
increase the study's validity and reliability by presenting eligible criteria: inclusion/ exclusion
factors, collecting appropriate data using different databases based on the research questions and
hypotheses of the study.
Research question:
RQ1: How is program dosage defined in correctional intervention research?
RQ2: How is program dosage measured in correctional intervention research?
Research design:
This thesis is a systematic review, a specific approach that identifies, evaluates, and
summarizes all relevant studies collected. To do so, inclusion and exclusion criteria were identified
to select more relevant studies for this study’s topic, program dosage.
Article Selection Search Strategy:
Sources of literature
The following databases were searched for both published and unpublished studies in the
English language between 1998 and 2019: Criminal Justice Abstract, Criminology Collection,
Dissertations & Theses Global, SCOPUS, SocINDEX, and Social Sciences Full Text. This study
also carried out an internet search using Google Scholar and ResearchGate to search for grey
literature and additional literature.
Eligible criteria
This research included a study based on the following criteria: (1) the study evaluated a
correctional intervention/treatment program, (2) the study include a measure of treatment dosage,
(3) the study include a risk-level of participants, (4) the study used either program completion or
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recidivism as study outcomes, (5) primary studies from any country, (6) the study published in
English from any country, and (7) the study that was published or unpublished between 1998 and
2019.
Search strategy
The following search terms were used to search for studies that met all 7 criteria mentioned
above across all databases: (dosage*) AND (recidivism) AND (risk-level) AND (correction or
correctional or correctional treatment or correctional intervention) OR (duration) OR (completion).
Coding:
This study aims to identify and analyze both published and unpublished studies on how
dosage is defined and its relationship to recidivism. To answer the research question, specific
information was required, such as a type of sample, correctional interventions, risk level, and
recidivism rate. Moreover, detailed information is described how those factors were identified and
coded in this study:

Table 1
Code Sheet
Description
Intervention setting
Treatment dosage
Recidivism

Age (in year)

Code/values
0 = institutional and community
1 = institutional-based
2 = community-based
1 = intensity
2 = duration
0 = multiple
1 = rearrest
2 = reconviction
3 = reincarceration
Mean number of year old they were at the time of treatment
participation
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Gender
Ethnicity
Criminal history

0 = female and male
1 = female
2 = male
0 = yes
1 = no
0 = multiple or any
1 = violent crime
2 = property offense
3 = drug-related offense

Study characteristics
Correctional interventions with two different setting, both institutional and community
based (0 = institutional and community), institutional-based (1 = institutional-based) or
community-based (2 = community-based), was used to see if there are any patters of how dosage
was defined in studies in different settings. In this systemic review, dosage was used to refer to
both duration and intensity. The treatment dosage was coded as to whether it was defined as either
intensity (1 = intensity), or only duration (2 = duration).
Recidivism is a fundamental concept with no exact measurement, so it was defined by
three different meanings. Each study used different definitions, which is appropriate to reach their
goal, and it was coded as rearrest (1 = rearrest), reconviction (2 = reconviction), reincarceration
(3 = reincarceration), or more than one definition (0 = more than one). Moreover, recidivism was
calculated as the number of rearrest, reconviction, or reincarceration rate of offenders who
participated in the program by percentage.
Sample Characteristics
The age of the sample was defined as the mean age at the time of treatment participation.
Participants’ gender was defined as Female and Male (0 = Female and Male), Female (1 = Female),
and Male (2 = Male). Ethnicity was not mentioned in every study; therefore, this variable was
coded to indicate whether race was identified in each study by Yes (0 = Yes) or No (1 = No).
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In the case of criminal records and risk levels measurement, coding is impossible because
each program did not use a unified measurement. Followed by, in terms of the unit of measurement
for each study such as the number of months, weeks, or hours were also presented differently.
Therefore, such variables will be mentioned in detail in Chapter Four which discusses the findings.
Data analysis
This thesis seeks to understand the definition and measurement of treatment dosage and
its effectiveness in reducing the recidivism rate in incarcerated individuals of all risk levels. To
answer this research question, this study expands on prior research by identifying studies that
defined treatment dosage in their research. Next, it examines how each study measured treatment
dosage – by treatment duration or intensity. Finally, to identify the most commonly used definition
and measurement of treatment dosage, it examines how each study applied different specifications
of treatment duration (hours and weeks) and intensity (number of program sessions) and recidivism
for different risk levels to reach study outcomes.
Summary
To understand the impact and definition of the treatment dosage to reduce recidivism,
different data were collected: definition of dosage, treatment type, treatment setting, the recidivism
rate of the assigned follow-up period, risk level, criminal history of participants was collected from
seven different pieces of research. As discussed above, those six researches were extracted based
on research strategies and the criteria mentioned. Data from organized studies were used to assess
each of the two research questions in the findings chapter. The following chapter will discuss the
detailed results of the current study and analyze the research question.
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Chapter Four: Findings
By identifying who benefits the most in correctional interventions with different treatment
dosages, we can learn how to allocate our resources and get the best outcomes from individuals
most in need of intervention. Therefore, this study contributes to the research on the impact of
treatment dosage on reducing recidivism and helping figure out consistent treatment dosage.
To begin with, there are six studies provided in this research to answer research questions:
how to define dosage and applied to individuals with different risk levels. Before analyzing these
studies, it will discuss how studies were reviewed and extracted.
Data extraction
Data were extracted based on characteristics of interest for the research questions. Each
study was coded for: population type, type of correctional interventions, setting of correctional
interventions, measurement of dosage, the definition of dosage, outcome measures, different risklevel, and criminal history of the population. Moreover, in Figure 1, a PRISMA model is provided
to illustrate how six studies were extracted.
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Figure 1: Search strategy based on the PRISMA model
Records identified through database
searching (Criminal Justice Abstract,
Criminology Collection, Dissertations &
Theses Global, SCOPUS, SocINDEX,
and Social Science Full Text)
(n = 134)

Additional records identified
through other sources (website
searching, citation tracking, and
google scholar
(n = 30)

Records after duplicates removed
(n = 81)

Records screened
(n = 81)

-

Studies excluded
Primary study (X)
Follow-up period (X)
Definition of dosage (X)
Measure of dosage (X)
Measure of risk level (X)
Measure of recidivism (X)
Recidivism as study
outcome (X)
(n = 39)

Full-text articles assessed
for eligibility
(n = 42)

Studies included in
qualitative synthesis
(n = 6)

Full-text articles excluded,
with reasons
- Criminal
history
of
population (X)
- Risk level of individuals
(X)
(n=36)
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Table.1 shows studies that have been included after the search, considering all the eligible
criteria and search strategies. Based on these studies, this chapter will identify how six studies
defined treatment dosage and its implementation for different risk levels.
Table 1: Research articles included in study
Author, year

Correctional Intervention

Intervention
setting

Participants

Dosage
measurement
(Duration/Intensity)

Bechtel, 2016

Community-based
correctional facilities (CCF)
programs

Institutionalbased

3281 male and female with a
criminal history of sexual
offense

Duration

Bourgon
and
Armstrong
,
2005
Makarios et al.,
2014

Cognitive-behavioral
program

Institutionalbased

Duration

Cognitive-behavioral
treatment

Communitybased

620 incarcerated male offenders
who served for at least one
violent offense
903 male with the criminal
history of felony charge without
mandatory prison time

Sperber et al.,
2013

Cognitive-behavioral
treatment

Community
based

689 adult male offenders with a
criminal history of a felony that
does not carry a mandatory
prison sentence

Duration

Sperber et al.,
2018

Cognitive-behavioral
treatment

Communitybased

257 adult males with a criminal
history of a felony but did not
require a mandatory prison term

Duration

Stewart et al.,
2014

Family violence prevention
program

Institutionalbased

572 male offenders have at least
one incident of assault of both
an intimate partner and others in
their personal history.

Intensity

-

Duration

Treatment duration:
Treatment duration is how long participants participated in the program, while treatment
intensity is how frequently they participated within a certain period. Five out of six studies defined
treatment dosage as treatment duration. Treatment duration was measured in three different ways
in these studies: hours, weeks, and months. Table 2 presented below shows the specific duration
that each study assigned to participants. However, as it shows, while these five studies used
treatment duration as dosage, they all had different ranges of treatment duration. For example, the

20

treatment duration of Makarios et al.’s (2014) research increased in increments of 50 hours, while
treatment duration in the study of Sperber et al. (2013) increased in increments of 100 hours.
Table 2: Study characterisitcs
Author, year

Definition of recidivism

Dosage
measurement

Follow-up
period

Duration

Bourgon and
Armstrong, 2005

Any incarceration as a result of a
new conviction or supervision
related breach during the followup period.

The number of weeks
of group treatment
each participant
received.

12 months

- 5 weeks
- 10 weeks
- 15 weeks

Bechtel, 2016

Any arrest, incarceration, or
technical violation offenses

- Number of months
- Number of hours

12 months

Number of months:
- 1 to 3 months
- 4 to 6 months
- 7 or more months
Number of hours:
- 0-99 hours
- 100-199 hours
- 200+ hours

Makarios et al.,
2014

The measure of recidivism used is
being sent to prison during the
follow-up period

Number of hours
participated

Minimum of 18
months, average
of 42 months

-

Sperber et al., 2013

Measure of recidivism if return to
prison

Number of hours
participated

Minimum of 12
months, average
of 19 months

- 0 to 99 hours
- 100 to 199 hours
- 200 or more
hours

Sperber et al., 2018

Defined as being sent to prison
during the follow-up period

Number of hours
participated

Average of 46
months

- 0 to 99 hours
- 100 to 199 hours
- 200 or more
hours

100 to 149 hours
150 to 199 hours
200 to 249 hours
250 to 299 hours
More than 300
hours

Bourgon and Armstrong, 2005
Bourgon and Armstrong (2005) studied whether prison-based treatment affects recidivism
reduction and found that treatment dosage plays an essential role. The study focused on 620
incarcerated male adult individuals, with a mean age of 32.1 years, serving sentences of no more
than two years between September 1997 and December 1999. Comprehensive structured cognitive
behavioral programs were provided to participants to change negative attitudes and behaviors and
increase prosocial thinking.
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To begin with, Bourgon and Armstrong (2005) defined recidivism as any incarceration
resulting from a new conviction or supervision-related violation during the one-year follow-up
period. In this study, treatment dosage was examined based on duration and measured in five-week
increments. The number of weeks of group treatment each participant received was based on
individual risk level. The program was a cognitive behavioral program that assisted in changing
participants’ negative attitudes and behaviors to build new skills and gain responsibility (Bourgon
& Armstrong, 2005). The duration of this program allowed appropriate application of the
principles of effective correctional treatment -- the 5-week program delivered approximately 100
hours, the 10-week program delivered approximately 200 hours, and the 15-week program
delivered approximately 300 hours of treatment (Bourgon & Armstrong, 2005)..
Each participant’s risk level was measured using Level of Service Inventory-Ontario
Revision (LSI-OR) scores gathered from file information and interviews (Bourgon & Armstrong,
2005). The study does not provide specific risk level categories, but it describes participants who
attended a 5-week program as “moderate risk” and 10- and 15-week program participants as “high
risk.” Participants were assigned to treatment programs based on these risk levels. A total of 83
individuals with an average LSI-OR score of 17.1 were assigned to a 5-week program. In
comparison, 107 individuals with an average LSI-OR score of 22.6 were assigned to participate in
a 10-week program, and 47 individuals with an average LSI-QR score of 25.1 were assigned to a
15-week program (Bourgon & Armstrong, 2005).
Overall, the study shows a significant relationship between the length of treatment and a
reduction in recidivism. Incarcerated participants who completed the 5-week program showed a
12% recidivism rate, while the untreated comparison group showed 28 percent. Moreover, for the
10-week program, the recidivism rate was 29.9%, compared to 43.8% for the untreated comparison
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group. Finally, the 15-week group had a 38.3% recidivism rate, while the untreated comparison
group’s rate was 59.1%. As these results indicate, all of the treated individuals, regardless of
treatment duration, showed significantly lower recidivism rates than those individuals who were
recommended to participate in treatment but did not complete it (Bourgon & Armstrong, 2005).
Table 3: Rate of recidivism by different dosage and risk level of treated and untreated group
Treated group
Treatment duration

LSI-OR score (risk level)

Untreated group
Recidivism (%)

LSI-OR score (risk level)

Recidivism (%)

5-week

17.1 (moderate)

12.0

18.3 (moderate)

28.0

10-week

22.6 (high)

29.9

22.5 (high)

43.8

15-week

25.1 (high)

38.3

26.8 (high)

59.1

Bourgon and Armstrong, 2005

Makarios et al., 2014
Makarios et al. (2014) carried out a study to identify the effectiveness of cognitive
behavioral treatment in reducing the likelihood of recidivism. The study used a sample of 903 adult
male non-sex offenders successfully discharged from a community-based correctional facility in
Ohio. The measure of recidivism used in Makarios et al.’s study was being sent to prison during
an average follow-up period of 45 months. Treatment dosage was defined as the number of hours
of group treatment and cognitive behavioral treatment activities.
Consistent with research by Sperber et al. (2013), each offender received treatment in 50hour increments, with the exception of those in the minimum dosage category, who received
between 0 and 99 hours of treatment (Makarios et al., 2014). Moreover, the risk level of each
individual was assessed using the Level of Service Inventory-Revised (LSI-R); based on these risk
scores, participants were categorized into five risk level groups: low risk, low-medium risk,
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medium risk, medium-high risk, and high risk. However, this study only examines low-medium
risk, medium, risk, and medium-high risk categories, due to a lack of data for the other groups.
Treatment dosage was categorized into six groups: minimum (0–99 hours), low (100–149
hours), low-medium (150–199 hours), medium-high (200–249 hours), high (250–299 hours), and
maximum (300+ hours) dosage. Each individual’s number of treatment hours was selected based
on risk level. Although there was no specific cut point in their implementation, Makarios et al.
attempted to increase programming and dosage for higher-risk cases and provide less dosage for
lower-risk cases (Makarios et al., 2014). After this method was carried out, the study examined the
impact of treatment dosage on recidivism for different risk categories and the relationship between
other specifications of the number of treatment hours and recidivism by risk level (Makarios et al.,
2014).
The study’s outcome shows a significant relationship between treatment dosage, risk level,
and recidivism rate. In the low-medium risk group, 14% of participants recidivated with 100-149
hours of treatment, while 30% recidivated with 150-199 hours of treatment. The moderate risk
group showed 40% incarcerated with100-149 hours, 37% with 200-249 hours, 38% with 250-299
hours, and 52% with more than 300 hours of treatment. Finally, unlike other risk level groups, the
high-moderate risk group shows a stark difference between specific dosage hours. This group
reached a 74% recidivism rate with 150-199 hours of treatment, which is relatively high among all
dosage categories and risk levels. Other rates for the high-moderate group included 47% with 200249 hours, 40% with 250-299 hours, and 38% with more than 300 hours of treatment. Makarios et
al.’s results indicated that a high treatment dosage does not always lead to a low recidivism rate,
and that it is important to match treatment dosage to the individual’s risk level.
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Table 4: Rate of recidivism by different dosage and risk level

Recidivism rate (%)
Dosage categories
(hours)
100-149

Low-medium risk

Medium risk

Medium-high risk

14

40

-

150-199

30

37

74

200-249

-

38

47

250-299

-

52

40

300+

-

-

38

Makarios et al., 2014

Sperber et al., 2013 and Sperber et al., 2018
Sperber et al. carried out studies in 2013 and 2018 to identify the relationship between risk
level and treatment dosage. There are many similarities between these two studies, though there
are some key differences, including targeted population and outcomes.
Beforehand, both Sperber et al., 2013 and 2018 research were held in community-based
correctional facility (CBCF) in Ohio with different participants and time-period. Sperber et al.’s
2013 study followed 689 adult male offenders who were successfully discharged from a CBCF for
a three-year period. The purpose of the study was to identify what treatment duration is necessary
to reduce recidivism in incarcerated participants placed in a CBCF. On the other hand, Sperber et
al.’s (2018) study followed 257 adult males convicted of felonies that did not require mandatory
prison terms, who were successfully discharged from a CBCF for a four-year period.
Both studies defined recidivism as being sent to prison during the follow-up period.
Treatment dosage was the number of hours of group treatment offenders received, in 100-hour
increments: 0-99 hours, 100-199 hours, and 200 or more hours of treatment. The risk level of
individuals was measured by the Level of Service Inventory-Revised (LSI-R) and categorized as
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low risk, moderate risk, and high-risk level (Sperber et al., 2013) and low-medium risk, medium
risk, and medium-high risk level (Sperber et al., 2018).
In their 2013 study, Sperber et al. applied the treatment dosage based on the individual’s
risk level; low-risk participants received lower dosage treatment. Based on this implementation,
39% of low-risk individuals in the group that received 0-99 hours of treatment returned to prison,
while 26% of those who received 100-199 hours returned to prison. For the moderate risk group,
52% returned to prison following 0-99 hours of treatment, 45% returned following 100-199 hours
of treatment, and 43% returned following more than 200 hours of treatment. For the high-risk
group, which shows the most significant differences, 81% of participants who received 100-199
hours of treatment returned to prison, while only 57% of participants who received more than 200
hours of treatment returned (Sperber et al., 2013).
Table 5: Rate of recidivism by different dosage and risk level

Recidivism rate (%)
Dosage categories
(hours)
0-99

Low-medium risk

Medium risk

Medium-high risk

39

52

-

100-199

26

45

81

200+

-

43

57

Sperber et al., 2013

Sperber et al.’s 2018 study also applied treatment dosage based on an individual’s risk
level, but this study shows a fairly different rate of recidivism during the follow-up period. 30%
of low-medium risk individuals who received 0-99 hours of treatment returned to prison, while
15% who received 100-199 hours of treatment returned. For the medium-risk group, 54% who
received 0-99 hours of treatment returned to prison, 42% who received 100-199 hours of treatment
returned, and 40% who received more than 200 hours of treatment returned. For the medium-high
risk group, which shows the most considerable differences, 85% of participants who received 100-
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199 hours of treatment returned to prison, while only 45% of participants who received more than
200 hours of treatment returned.
Table 6: Rate of recidivism by different dosage and risk level

Recidivism rate (%)
Dosage categories
(hours)
0-99

Low-medium risk

Medium risk

Medium-high risk

39

52

-

100-199

26

45

81

200+

-

43

57

Sperber et al., 2018

Bechtel, 2016
Table 7: Study characteristics of Bechtel, 2016
Author, year

Definition of
recidivism

Bechtel, 2016

any arrest, incarceration,
or technical violation
offenses

Dosage measurement
- Number of months
- Number of hours

Follow-up period
12 months

duration
Number of months:
- 1 to 3 months
- 4 to 6 months
- 7 or more months
Number of hours:
- 0-99 hours
- 100-199 hours
- 200+ hours

Bechtel, 2016

Bechtel (2016) defined recidivism as an offender experiencing any new arrest,
incarceration, or technical violation offense during twelve months of follow-up after release. In
this study, unlike other four studies mentioned above, program duration was examined in two
different ways as it was identified in Table 7: the number of months and number of hours
participants participated in the program. Each duration was categorized into three groups. The
number of months was categorized as 1-3 months, 4-6 months, or 7 or more months. The number
of hours was categorized as 0-99 hours, 100-199 hours, or 200 or more hours (Bechtel, 2016).
Individual risk level was assessed using the Level of Service Inventory-Revised (LSI-R).
This assessment tool indicated three risk levels: low, moderate, and high (Bechtel, 2016). However,
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unlike in the aforementioned studies, the numbers of months and hours were not applied based on
the risk levels of participants. The results were then compared to determine the most effective
dosage. For example, the low-risk group was divided into three groups and assigned to 1-3 months,
4-6 months, and 7 or more months and to 0-99 hours, 100-199 hours, or 200 hours or more of
program duration.
Based on the results, the total of group hours has a statistically significant relationship
with technical violation, incarceration, and any type of recidivism (Bechtel, 2016). Specifically,
the low-risk group showed the lowest recidivism rate when they received 0-99 hours of treatment.
For the moderate- risk group, 0-99 hours of treatment duration was effective in reducing all crime
types. The high-risk level group showed the lowest rate of recidivism after 100-199 hours of
treatment. Although each risk level group showed a different recidivism rate based on their
criminal history and treatment duration, each group displayed the same pattern with 200 or more
hours of treatment, which increased the likelihood of recidivism rather than reducing it (Bechtel,
2016).
The study also showed multiple statistically significant relationships between the number
of program months and recidivism of any kind. For the low-risk group, 1-3 months of treatment
showed the highest overall recidivism rate compared to the other dosage groups. The most
significant decrease in recidivism rate for all types of crime was found in those who participated
in 7 or more months of programming. The moderate-risk group showed a low rate of overall
recidivism among participants who participated in an average of 4-6 months of treatment, while
the high-risk level group showed a low recidivism rate with an average of 7 or more months of
treatment (Bechtel, 2016).
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Treatment intensity:
Stewart et al., 2014
Only one out of six studies defined treatment dosage as treatment intensity rather than as
treatment duration. Treatment intensity is defined as how frequently participants participated in
the program. In their 2014 study, Stewart et al. defined it as the number of program sessions: either
25 sessions or 78 sessions.
Stewart et al. (2014) evaluated a family violence prevention program for 572 male
offenders, ranging from 20 to 69 years, with an average age of 37 years. These men were
incarcerated at various federal institutions across Canada between 1999 and 2003. The study
included untreated groups to help identify the significant effects of treatment on reducing
recidivism rates for each risk level group and type of crime.
Table 8: Characteristics of Stwart et al., 2014
Author, year
Definition of recidivism
Stewart et al.,
2014

Rearrest, another charge,
and reconviction

Dosage
measurement
Number of
session

Follow-up
period
6 months

Intensity
- 25-session program
- 78-session program

Stewart et al. (2014) measured recidivism as any rearrest, recharge, or reconviction due to
domestic violence during the six-month follow-up period. As mentioned above, in this study,
treatment dosage was defined as the number of program sessions. Two programs were provided: a
25-session program identified as “moderate intensity,” and a 78-session program identified as
“high intensity.” The number of sessions was assigned based on each participant’s risk level. The
risk level was measured using SARA, a structured risk assessment tool that assesses the risk for
domestic violence to guide monitoring and intervention (Stewart et al., 2014).
Based on the risk assessment tool, moderate and high-risk groups of participants were
identified. The program assigned moderate-risk participants to attend the moderate-intensity
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program, while high-risk individuals were assigned to the high-intensity program (Stewart et al.,
2014). Of the 246 total incarcerated participants, 127 individuals were assigned to the moderateintensity program, with 76 treated and 51 untreated; meanwhile, 119 were assigned to the highintensity program, with 84 treated and 35 untreated. The study compared the recidivism rate of
each treated and untreated group of people in both intensity programs based on three different
crime categories: spousal violence, any violence, and any infraction (Stewart et al., 2014). Spousal
violence was defined as any actual, attempted, or threatened violence towards a past or current
intimate partner, any violence was defined as violence toward spouses and others, and any
infraction referred to all criminal behavior and conditional release violations, regardless of whether
they resulted in arrest (Stewart et al., 2014).
The study’s outcome shows a correlation between treatment intensity, risk level, and
recidivism rate. For the moderate-intensity group, 4% of the treated group committed a spousal
violence offense, while 14% did in the untreated group; this is a 71% reduction in spousal assault
recidivism. For both violence and infraction offenses, the study shows the same trends of
recidivism, but the differences are not statistically significant (Stewart et al., 2014). The highintensity group also showed a significant difference between the treated and untreated groups for
spousal violence and any violent offenses: 4% of the treated group committed spousal violence
offenses, while 14% of the untreated group did. 11% of the treated group were indicted for
committing any violence, while 26% of the untreated group were indicted. Furthermore, 11% of
the treated group and 26% of the untreated group committed new violent offenses; this means that
violent recidivism was reduced by nearly 60% (Stewart et al., 2014).
Table 9: Recidivism rates for treated and untreated group

Moderate intensity group

High intensity group
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Treated

Untreated

Treated

Untreated

Spousal violence 4%

12%

4%

14%

Any violence

9%

14%

24%

37%

Any infraction

24%

26%

24%

37%

Stewart et al., 2014
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Chapter Five: Discussion
This systemic review seeks to examine the definition and measurement of treatment
dosage and its effect on recidivism at different risk levels. It was designed to broaden our
understanding of how treatment dosage has been applied to correctional intervention research. To
date, there is no generalized standard definition and measurement of treatment dosage. For this
reason, each study presents different treatment dosages for each individual intervention. Therefore,
six studies were gathered and examined to provide an idea of the most commonly used treatment
dosages in correctional interventions to reduce the recidivism rate.
Definition of treatment dosage
Treatment dosage is measured in a variety of ways. However, two main factors are often
used to define treatment dosage: treatment duration (Bourgon & Armstrong, 2005; Bechtel, 2016;
Makarios et al., 2014; Sperber et al., 2013; Sperber et al., 2018) and treatment intensity (Stewart
et al., 2014). Treatment duration is how long participants participated in a program; it can be
measured in hours, weeks, or months. On the other hand, treatment intensity is how frequently
participants participated within a certain period of time; it is usually measured by the number of
program sessions.
Six studies were extracted based on the criteria for the current study. Although different
measurements were used in each, five out of the six studies defined treatment dosage as treatment
duration. Based on these findings, we can conclude that treatment duration the preferred definition
of treatment dosage for reducing recidivism in criminal interventions. Treatment duration was not
simply used more often in these studies to define treatment dosage than treatment intensity; it also
proved to produce statistically significant reductions in recidivism rates of participants during their
follow-up periods.
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Measurement of treatment dosage
Treatment dosage has no generalized standard for its measurement. While five of the
studies examined in this thesis used the same definition of treatment dosage (treatment duration),
each study measured it differently, with different units of measurement.
To begin with, the studies did not use a fixed number of hours; however, three general
measurements of treatment duration were identified: the number of months (Bechtel, 2016),
number of weeks (Bourgon & Armstrong, 2005), and number of hours (Makarios et al., 2014;
Sperber et al., 2013; Sperber et al., 2018) each participant spent in a program. The units of
measurement for the number of months were categorized into three groups: 1-3 months, 4-6
months, and 7 or more months. The units of measurement for the number of weeks was also
categorized into three groups: 5-week, 10-week, and 15-week programs (Bourgon & Armstrong,
2005). Unlike the units of measurement of months and weeks, two different sets of units are
presented for the number of program hours. The first set of units for the number of hours is 0-99
hours, 100-199 hours, and 200 or more hours (Sperber et al., 2013; Sperber et al., 2018); the second
set is 100-149 hours, 150-199 hours, 200-249 hours, 250-299 hours, and 300 or more hours
(Makarios et al., 2014).
Treatment intensity was measured by the number of sessions each participant participated
in during a certain period. There is no fixed number of sessions; however, Stewart et al. (2014)
presented the units of measurement for treatment intensity as a 25-session program and a 78session program over a 4-year period.
Relationship between treatment dosage and risk level on recidivism rate
All six studies presented in Chapter Four showed that applying treatment dosage
appropriately to the different risk levels of participants effectively lowers the recidivism rate.
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However, since these studies were all conducted under different conditions, it is difficult to
determine which treatment dosage was most effective and develop a standard for the future.
Moreover, it is hard to identify which intervention was most effective among all six studies,
because the meaning of treatment dosage and all other factors were approached differently for each
study.
However, putting aside other factors such as criminal types, ages, treatment types, and so
on, a simple pattern can be observed in relation to which treatment dosage most effectively reduces
the recidivism rate of participants. Looking at the most frequently used measurement, hours, and
its relationship with the recidivism rate for different risk levels, one can see that moderate-risk
groups were less likely to recidivate when they received 150-200 hours of treatment. In comparison,
high-risk groups showed the lowest recidivism rate when they participated in more than 200 hours
of the treatment.
When all experiments are conducted under the same conditions, comparison is relatively
easy, and it is thus easy to find the most effective method. In this case, however, it is challenging,
because all variables other than the definition and measurement of treatment dosage differ in each
study. There are differences in quality of experiment conducted, definition of recidivism rate, type
of correctional intervention, intervention setting, follow-up period, and measurement used to
identify risk level. Moreover, one of the most critical variables, the target population, differs among
the studies in terms of age range, gender, criminal history, ethnicity, and serving time. If these
factors were the same, it might have been possible to find the most effective way to apply treatment
dosage in a correctional intervention to reduce recidivism and solve the most fundamental
problems by providing a general standardized definition and measurement of treatment dosage.
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Recommendation for future study
Although the six studies reviewed in this thesis have shown that treatment dosage lowers
the recidivism rate for different risk levels, there is no one clear answer as to how treatment dosage
should be defined or measured. However, if I were to recommend a new correctional intervention
for future studies, I would suggest defining treatment dosage as treatment duration. In this study
alone, this measurement was used by five out of six papers.
Unlike the definition of treatment dosage, the ideal measurement of treatment dosage
cannot be determined based on the frequency of usage. Therefore, using more than one
measurement, as in Bechtel (2016) study, will be very helpful in enhancing research literacy.
Additionally, I would choose the same measurement as Bechtel (2016): the number of months and
hours. To be more specific, I would choose ranges of 1-3 months, 4-6 months, and 7 or more
months, along with ranges of 0-99 hours, 100-199 hours, and 200 or more hours. The results of
this paper show that this approach successfully lowered the recidivism rate; the relationship
between treatment dosage, individual risk levels, and recidivism rates was also very wellillustrated when these measurements were used.
Limitation of this study
The main limitation of this study is a lack of resource availability -- it has too few
references and too little information to fully answer the research questions. This is because data
search was limited to six databases, which brought only published research to answer the research
questions while inclusion criteria includes unpublished literature as well. Since this is the case,
although there is limited information in this field, more data must be searched and identified for
further study. It would be beneficial to expand the scope of thesis research and expand the
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databases to find the grey literature and unpublished literature, which contain insights that may not
be found in published work.
Moreover, the intervention settings of the studies were too limited; only institutional-based
and community-based interventions were considered. To identify the appropriate implementation
of treatment dosage for successfully reducing recidivism, a wider variety of intervention settings
should be considered (e.g., residential-based intervention). Additionally, treatment targets in this
thesis included only adults; juveniles were excluded entirely. Therefore, the outcome of this thesis
cannot be applied to other studies.
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Conclusion
Although treatment dosage plays an essential role in successfully reducing recidivism
rates, it has no generalized standard measurement. This thesis examined six studies and determined
that treatment duration was often used to define treatment dosage and showed statically significant
outcomes – participants of different risk levels who participated in correctional intervention after
their release from prison showed reduced recidivism rates when this approach was taken. Based
on the findings of the six studies, treatment duration appears to be the preferable definition of
treatment dosage. However, due to a lack of resources and unified data, this thesis cannot
completely confirm that treatment duration is the best dosage to apply. Regardless of participants’
risk levels, other variables such as type of criminal history, length of follow-up period, and unit of
treatment dosage must be the same across studies in order to determine whether treatment duration
is the most appropriate definition to implement. A wider variety of intervention types and settings,
treatment targets, and other variables could also provide a more accurate picture of which treatment
dosage definitions and measurements are most appropriate for incarcerated individuals with
different risk levels.

37

Key Terms
Follow-up period: period commencing immediately after the release from the prison
Recidivism: rearrest, reconviction, or reincarceration during the follow up period
Risk level: offender’s risk of recidivism which often labeled as low-risk, moderate-risk, and highrisk level
Treatment duration: how long participants participated in the program
Treatment intensity: how frequently they participated within a certain period

38

References
Allen, L. C., MacKenzie, D. L., & Hickman, L. J. (2001). The effectiveness of cognitive
behavioral treatment for adult offenders: A methodological, quality-based
review. International Journal of Offender Therapy and Comparative Criminology, 45(4),
498–514. https://doi.org/10.1177/0306624x01454009
Alper, M., Durose, M. R., & Markman, J. (2018). 2018 Update on Prisoner Recidivism: A 9Year Follow-up Period (2005-2014). Recidivism of Prisoners Released.
Andrews, D. A., Bonta, James., & Hoge, R. D. (1990). Classification for Effective
Rehabilitation. Criminal Justice and Behavior, 17(1), 19–52.
https://doi.org/10.1177/0093854890017001004
Andrews, D. A., Bonta, J., & Wormith, J. S. (2011). The risk-need-responsivity (RNR)
model. Criminal Justice and Behavior, 38(7), 735–755.
https://doi.org/10.1177/0093854811406356
Ashley, O. S., Marsden, M. E., & Brady, T. M. (2003). Effectiveness of Substance Abuse
Treatment Programming for Women: A Review. The American Journal of Drug and
Alcohol Abuse, 29(1), 19–53. https://doi.org/10.1081/ada-120018838
Bechtel, K. A. (2016). Adherence to the Risk, Need and Fidelity Principles: Examining the
Impact of Dosage in Correctional Programming.
Bourgon, G., & Armstrong, B. (2005). Transferring the principles of effective treatment into a
“real world” prison setting. Criminal Justice and Behavior, 32(1), 3–25.
https://doi.org/10.1177/0093854804270618
Calley, N. G. (2012). Juvenile offender recidivism: An examination of risk factors. Journal of
Child Sexual Abuse, 21(3), 257–272. https://doi.org/10.1080/10538712.2012.668266
Cohen, T. H., Lowenkamp, C. T., & VanBenschoten, S. W. (2016). Does change in risk
matter? Criminology & Public Policy, 15(2), 263–296. https://doi.org/10.1111/17459133.12190
Collins, L. M., Murphy, S. A., & Bierman, K. L. (2004). A conceptual framework for adaptive
preventive interventions. Prevention Science, 5(3), 185–196.
https://doi.org/10.1023/b:prev.0000037641.26017.00
Cotter, R. (2020, April). Length of incarceration and recidivism. United States Sentencing
Commission. Retrieved from https://www.ussc.gov/research/research-reports/lengthincarceration-and-recidivism.

39

Davis, L. M., Bozick, R., Steele, J. L., Saunders, J., & Miles, J. (2013). The Relationship
Between Correctional Education and Recidivism. In Evaluating the effectiveness of
correctional education: A meta-analysis of programs that provide education to
incarcerated adults (pp. 27–40). essay, RAND Corporation.
Davis, L. M., Steele, J. L., Bozick, R., Williams, M. V., Turner, S., Miles, J., Saunders, J., &
Steinberg, P. S. (2014). How Effective Is Correctional Education for Incarcerated Adults?
In How effective is correctional education, and where do we go from here?: The results of
a comprehensive evaluation (pp. 7–19). essay, RAND Corporation.
Duncan, J., Stansfield, R., Hall, S., & O’Connor, T. (2018). Women’s engagement with
humanist, spiritual and religious meaning-making in prison: A longitudinal study of its
impact on recidivism. Religions, 9(6), 171. https://doi.org/10.3390/rel9060171
Durose, M. R., & Antenangeli, L. (2021). Recidivism of prisoners released in 34 states in 2012:
A 5-year follow-up period (2012–2017). Bureau of Justice Statistics. Retrieved from
https://bjs.ojp.gov/library/publications/recidivism-prisoners-released-34-states-2012-5year-follow-period-2012-2017.
Duwe, G. (2018). The effects of the timing and dosage of correctional programming on
recidivism. Journal of Offender Rehabilitation, 57(3-4), 256–271.
https://doi.org/10.1080/10509674.2017.1401025
Haerle, D. R. (2014). Dosage matters. Youth Violence and Juvenile Justice, 14(1), 3–25.
https://doi.org/10.1177/1541204014555436
Hall, L. L. (2015). Correctional Education and Recidivism: Toward a Tool for
Reduction. Correctional Education Association, 66.
Hollin, C. R. (1999). Treatment Programs for Offenders: Meta-Analysis, “What Works,” and
Beyond. International Journal of Law and Psychiatry, 22.
Jancic, M. (1998). Does Correctional Education Have an Effect on Recidivism? Correctional
Education Association, 49(4).
Keeling, J. A., Rose, J. L., & Beech, A. R. (2006). An investigation into the effectiveness of a
custody-based cognitive-behavioural treatment for special needs sexual offenders. Journal
of Forensic Psychiatry & Psychology, 17(3), 372–392.
https://doi.org/10.1080/14789940600658293
Landenberger, N. A., & Lipsey, M. W. (2005). The positive effects of cognitive–behavioral
programs for offenders: A meta-analysis of factors associated with effective
treatment. Journal of Experimental Criminology, 1(4), 451–476.
https://doi.org/10.1007/s11292-005-3541-7

40

Latessa, E. J., & Lowenkamp, C. (2006). What works in reducing recidivism. University of St.
Thomas Law Journal, 3(3), 521-535.
Lipsey, M. W., Chapman, G. L., & Landenberger, N. A. (2001). Cognitive-Behavioral Programs
for Offenders. Annals of the American Academy of Political and Social Science.
Mailloux, D. L., Abracen, J., Serin, R., Cousineau, C., Malcolm, B., & Looman, J. (2003).
Dosage of treatment to sexual offenders: Are we overprescribing? International Journal of
Offender Therapy and Comparative Criminology, 47(2), 171–184.
https://doi.org/10.1177/0306624x03251096
Makarios, M., Sperber, K. G., & Latessa, E. J. (2014). Treatment dosage and the risk principle:
A refinement and extension. Journal of Offender Rehabilitation, 53(5), 334–350.
https://doi.org/10.1080/10509674.2014.922157
McCollister, K. E., French, M. T., Inciardi, J. A., Butzin, C. A., Martin, S. S., & Hooper, R. M.
(2003). Post-release substance abuse treatment for criminal offenders: A cost-effectiveness
analysis. Journal of Quantitative Criminology, 19(4), 389–407.
https://doi.org/10.1023/b:joqc.0000005441.49529.61
Office of Justice Programs, & Carson, A., Prisoners in 20191–37 (2020). Bureau of Justice
Statistics.
Office of Justice Programs, & Duwe, G., The use and impact of correctional programming for
inmates on pre- and post-release outcomes1–39 (2017). Washington, DC; National
Institute of Justice.
Pearson, F. S., Lipton, D. S., Cleland, C. M., & Yee, D. S. (2002). The effects of
behavioral/cognitive-behavioral programs on recidivism. Crime & Delinquency, 48(3),
476–496. https://doi.org/10.1177/001112870204800306
Peters, R. H., Haas, A. L., & Hunt, W. M. (2001). Treatment “dosage” effects in Drug Court
programs. Journal of Offender Rehabilitation, 33(4), 63–72.
https://doi.org/10.1300/j076v33n04_04
Rowbotham, S., Conte, K., & Hawe, P. (2019). Variation in the operationalisation of dose in
implementation of health promotion interventions: Insights and recommendations from a
scoping review. Implementation Science, 14(1). https://doi.org/10.1186/s13012-019-0899x
Seewald, K., Rossegger, A., Gerth, J., Urbaniok, F., Phillips, G., & Endrass, J. (2018).
Effectiveness of a risk-need-responsivity-based treatment program for violent and sexual
offenders: Results of a retrospective, quasi-experimental study. Legal and Criminological
Psychology, 23(1), 85–99. https://doi.org/10.1111/lcrp.12122

41

Sperber, K. G., Latessa, E. J., & Makarios, M. D. (2013). Examining the interaction between
level of risk and dosage of treatment. Criminal Justice and Behavior, 40(3), 338–348.
https://doi.org/10.1177/0093854812467942
Sperber, K. G., & Lowenkamp, C. T. (2017). Dosage is more than just counting program hours:
The importance of role-playing in treatment outcomes. Journal of Offender
Rehabilitation, 56(7), 433–451. https://doi.org/10.1080/10509674.2017.1359222
Sperber, K. G., Makarios, M. D., & Latessa, E. J. (2018). Exploring the Risk-Dosage
Relationship in Offenders Classified as Neurotic. Journal of Community Corrections, 27,
9-13(5).
Stewart, L. A., Gabora, N., Kropp, P. R., & Lee, Z. (2014). Effectiveness of risk-needsresponsivity-based family violence programs with male offenders. Journal of Family
Violence, 29(2), 151–164. https://doi.org/10.1007/s10896-013-9575-0
Taxman, F. S., & Marlowe, D. (2006). Risk, needs, responsivity: In action or inaction? Crime &
Delinquency, 52(1), 3–6. https://doi.org/10.1177/0011128705281757
Turner, B. W., Bingham, J. E., & Andrasik, F. (2000). Short-term community-based treatment
for sexual offenders: Enhancing effectiveness. Sexual Addiction & Compulsivity, 7(3),
211–223. https://doi.org/10.1080/10720160008400219
United States Sentencing Commission, Hunt, K. S., Iaconetti, M., & Maass, K., Recidivism
among federal violent offenders1–68 (2019). One Columbus Circle, DC; United States
Sentencing Commission.
United States Sentencing Commission, Kyckelhahn, T., & Cooper, T., The Past Predicts the
Future: Criminal History and Recidivism of Federal Offenders1–17 (2017). One Columbus
Circle, DC; United States Sentencing Commission.
Ward, T., & Brown, M. (2004). The good lives model and conceptual issues in offender
rehabilitation. Psychology, Crime & Law, 10(3), 243–257.
https://doi.org/10.1080/10683160410001662744
Ward, T., Fisher, S., & Beech, A. (2016). An integrated theory of sexual offending. Sexual
Offending, 1–11. https://doi.org/10.1007/978-1-4939-2416-5_1
Ward, T., Melser, J., & Yates, P. M. (2007). Reconstructing the risk–need–responsivity model: A
theoretical elaboration and evaluation. Aggression and Violent Behavior, 12(2), 208–228.
https://doi.org/10.1016/j.avb.2006.07.001
Wikoff, N., Linhorst, D. M., & Morani, N. (2012). Recidivism among participants of a reentry
program for prisoners released without supervision. Social Work Research, 36(4), 289–
299. https://doi.org/10.1093/swr/svs021

42

Winokur, K. P., Cass, E., & Blankenship, J. (2003). Juvenile Recidivism and Length of
Stay. National Center for Juvenile Justice.
Wright, S. (2019). Evaluating What Promotes Pro-Social Learning in Justice-Involved Adults: A
Quantitative Study of Outcomes after Release from Short-term Confinement.

